MarketGrader Indexes – 2023 Performance Review

MarketGrader’s stock selection methodology shone in 2023, as 75% of our indexes outperformed their benchmarks in what turned out to be a strong year for most equity markets around the world.

The U.S. Election & Health Care Stocks

The best outcome of the recent U.S. election that health care investors could have hoped for was a divided government, and they got it (or

Barron's 400 Index logo

The Barron’s 400: GARP vs. Size – Week Ending October 30th

Using the Barron’s 400 Index as a proxy for a portfolio holding GARP companies, the GARP vs. Size blog is a weekly summary of the performance of US equity markets aimed at informing readers the alpha that is attainable using a GARP focused stock picking strategy

Research
Publications

MarketGrader Indexes – 2023 Performance Review

MarketGrader’s stock selection methodology shone in 2023, as 75% of our indexes outperformed their benchmarks in what turned out to be a strong year for most equity markets around the world.

U.S. Equities: Our Latest Views

Investors Continue to Underestimate the Impact Higher Interest Rates Are Having Across the Economy. Beware Expensive Large Cap Stocks.

Get Access to the World’s Smartest Global Research Platform

Don’t wait another day to make better informed, higher-returning investments.

investor professional trading stock